Karin Egberts
Overview
Explore the profile of Karin Egberts including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
859
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Watson H, Thornton L, Yilmaz Z, Baker J, Coleman J, Adan R, et al.
Biol Psychiatry Glob Open Sci
. 2022 Nov;
2(4):368-378.
PMID: 36324647
Background: Genetics and biology may influence the age of onset of anorexia nervosa (AN). The aims of this study were to determine whether common genetic variation contributes to age of...
12.
Fekete S, Kulpok C, Taurines R, Egberts K, Geissler J, Gerlach M, et al.
J Neural Transm (Vienna)
. 2022 Nov;
130(1):53-63.
PMID: 36324035
Psychotropic drugs are frequently prescribed 'off-label' to children and adolescents and carry the risk of serious adverse drug reactions (sADR). We examined the frequency of sADRs of psychotropic drugs in...
13.
Zheng Y, Rajcsanyi L, Herpertz-Dahlmann B, Seitz J, de Zwaan M, Herzog W, et al.
Transl Psychiatry
. 2022 Jun;
12(1):241.
PMID: 35680849
Genetic factors are relevant for both eating disorders and body weight regulation. A recent genome-wide association study (GWAS) for anorexia nervosa (AN) detected eight genome-wide significant chromosomal loci. One of...
14.
Egberts K, Fekete S, Hage A, Hiemke C, Scherf-Clavel M, Taurines R, et al.
Z Kinder Jugendpsychiatr Psychother
. 2022 Mar;
50(2):133-152.
PMID: 35274573
Therapeutic drug monitoring to optimize psychopharmacotherapy in children and adolescents - Update and guidelines for practice Despite the improved evidence base, many uncertainties remain in child and adolescent psychiatric pharmacotherapy...
15.
Borsdorf B, Dahmen B, Buehren K, Dempfle A, Egberts K, Ehrlich S, et al.
J Psychiatry Neurosci
. 2021 Oct;
46(5):E568-E578.
PMID: 34654737
Background: Brain-derived neurotrophic factor (BDNF) influences brain plasticity and feeding behaviour, and it has been linked to anorexia nervosa in numerous studies. Findings in mostly adult patients point to reduced...
16.
Focker M, Timmesfeld N, Buhlmeier J, Zwanziger D, Fuhrer D, Grasemann C, et al.
Nutrients
. 2021 Aug;
13(7).
PMID: 34371865
(1) Background: Evidence has accumulated that patients with anorexia nervosa (AN) are at higher risk for vitamin D deficiency than healthy controls. In epidemiologic studies, low 25(OH) vitamin D (25(OH)D)...
17.
Fekete S, Scherf-Clavel M, Gerlach M, Romanos M, Kittel-Schneider S, Unterecker S, et al.
Pharmacopsychiatry
. 2020 Dec;
54(3):117-125.
PMID: 33291155
Objective: Comparative pharmacokinetic data about the antidepressant venlafaxine (VEN) and the antipsychotic drug risperidone (RIS) over the lifespan and especially in children and adolescents is lacking. This is the first...
18.
Egberts K, Reuter-Dang S, Fekete S, Kulpok C, Mehler-Wex C, Wewetzer C, et al.
J Neural Transm (Vienna)
. 2020 Sep;
127(12):1663-1674.
PMID: 32997183
Although aripiprazole is one of the most used antipsychotics, knowledge about serum concentrations in children and adolescents is scarce and age-specific therapeutic ranges have not been established yet. Data of...
19.
Munn-Chernoff M, Johnson E, Chou Y, Coleman J, Thornton L, Walters R, et al.
Addict Biol
. 2020 Feb;
26(1):e12880.
PMID: 32064741
Eating disorders and substance use disorders frequently co-occur. Twin studies reveal shared genetic variance between liabilities to eating disorders and substance use, with the strongest associations between symptoms of bulimia...
20.
Unterecker S, Hefner G, Baumann P, Grunder G, Bergemann N, Clement H, et al.
Nervenarzt
. 2019 Jul;
90(9):958-960.
PMID: 31309271
No abstract available.